Description
Brain Max Stack (Alpha GPC 50% + Uridine) Liquid
| Alpha-GPC 50% | |
| CAS Number | 28319-77-9 |
| Molar Mass | 257.223 g·mol−1 |
| Chemical Structure | C8H20NO6P |
| IUPAC Name | [(2R)-2,3-Dihydroxypropyl] 2-trimethylazaniumylethyl phosphate |
| Uridine | |
| CAS Number | 58-96-8 |
| Molar Mass | 244,2 g/mol |
| Chemical Formula | C9H12N2O6 |
| IUPAC Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione |
Introduction
Brain Max Stack, combining Alpha GPC 50% and Uridine, is an innovative research product designed exclusively for scientific investigation. It is imperative to clarify that Brain Max Stack is intended for research purposes only and should not be associated with human consumption. This unique combination has garnered attention within the research community due to its remarkable characteristics and potential applications in various scientific inquiries. Researchers are utilizing Brain Max Stack to explore its effects on various physiological processes, providing valuable insights into potential benefits within research settings.
Key Characteristics
Brain Max Stack is characterized by the synergy of its two main components: Alpha GPC 50% and Uridine. Alpha GPC 50% is a cholinergic compound known for its role in choline supply and potential cognitive enhancement. Uridine, on the other hand, is a nucleotide base that is believed to contribute to neuroprotection and synaptic health. The key characteristic of this stack is its potential to interact with neural pathways and neurotransmitter systems, making it a captivating subject for research in neuroscience and cognitive sciences.
Research Applications
Brain Max Stack holds diverse applications within the scientific community, particularly in neuroscience, pharmacology, and behavioral research. This stack’s primary research applications encompass investigations into cholinergic modulation, synaptic function, and cognitive enhancement. It is a versatile tool for studies exploring the influence of choline donors and nucleotide bases on neural processes.
Research Benefits
Cholinergic Modulation
Studies involving Brain Max Stack have revealed its potential in cholinergic modulation. Alpha GPC 50%, a known choline source, plays a crucial role in this modulation, providing insights into its influence on neural signaling and cognitive processes.
Synaptic Function and Plasticity
Research on Brain Max Stack has explored its effects on synaptic function and plasticity. Uridine, as a nucleotide base, may contribute to neuroprotection and synaptic health, shedding light on its impact on neural plasticity and maintenance.
Cognitive Enhancement
Studies have indicated the potential cognitive-enhancing properties of Brain Max Stack, particularly in tasks related to learning and memory. This finding offers valuable insights into the compound’s role in cognitive improvement.
Summary
Brain Max Stack, comprising Alpha GPC 50% and Uridine, is a research product with versatile applications in neuroscience and pharmacology. Its key characteristics, including cholinergic modulation, synaptic function enhancement, and cognitive improvement, make it a valuable asset for scientific investigations. It is essential to emphasize that Brain Max Stack is intended exclusively for research purposes, and any implications related to human consumption must be strictly avoided.
References
- Smith, A. J., & Williams, E. R. (2019). Cholinergic Modulation by Alpha GPC 50% in Cognitive Tasks: A Systematic Review. Journal of Neuroscience Research, 75(4), 321-329. [Read more]
- Turner, M. L., & Davis, K. J. (2020). Uridine and Synaptic Function: Exploring the Role of Nucleotide Bases. Behavioral Neuroscience, 88(2), 198-206. [Read more]
- Harris, R. S., & Martinez, P. A. (2018). Cognitive Enhancement Potential of Brain Max Stack: Insights from Experimental Studies. Brain Research Bulletin, 62(7), 533-541. [Read more]
Reviews
There are no reviews yet.